JP Morgan Maintains Overweight on Biohaven, Raises Price Target to $35
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
JP Morgan analyst Tessa Romero maintains Biohaven (NYSE:BHVN) with a Overweight and raises the price target from $14 to $35.
JP Morgan analyst Tessa Romero maintains Biohaven (NYSE:BHVN) with a Overweight and raises the price target from $14 to $35.
